Evidence map›Paper›PMID 29876836›Full record

ArticleJournal of endocrinological investigation2019

Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma.

Y Luo, Y Zhao, K Chen, J Shen, J Shi, S Lu, J Lei, Z Li, D Luo

Open access · hybridAbstract read
In one paragraph

Article in Journal of endocrinological investigation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Y LuoWest China School of Medicine, Sichuan University, Sichuan, China.
Y ZhaoDepartment of General Surgery, Zhang jia-gang First People's Hospital, Jiangsu, China.
K ChenDepartment of General Surgery, Zhang jia-gang First People's Hospital, Jiangsu, China.
J ShenNanjing Medical University, Jiangsu, China.
J ShiDepartment of Surgical Oncology, Hangzhou First People's Hospital, Nanjing Medical University, No. 261, Huansha Road, Shangcheng district, Hangzhou, 310006, Zhejiang, China.
S LuZhejiang Chinese Medical University, Zhejiang, China.
J LeiThyroid Surgery, West China Hospital of Sichuan University, Chengdu, China.
Z LiWest China School of Medicine, Sichuan University, Sichuan, China.
D LuoDepartment of Surgical Oncology, Hangzhou First People's Hospital, Nanjing Medical University, No. 261, Huansha Road, Shangcheng district, Hangzhou, 310006, Zhejiang, China. ldc65@163.com.ORCID http://orcid.org/0000-0002-7320-4202
Sichuan University · CNHangzhou First People's Hospital · CNSoochow University · CNNanjing Medical University · CNZhejiang Chinese Medical University · CN

Funding

Key Project of Scientific and Technological Innovation in Hangzhou 20131813A08
6 · The paper itself

Abstract

purposeLymph node metastasis (LNM) is a vital prognosis factor in patients with papillary thyroid microcarcinoma (PTMC). The study tried to identify clinicopathological factors for LNM of PTMC.

methodsThe clinicopathological data of 1031 patients with PTMC were extracted and analyzed. Univariate and multivariate analyses were used to identify risk factors associated with cervical lymph node metastasis. ROC analysis was used to determine the ideal critical points of the sum of the maximum diameter of multifocal in a unilateral lobe.

resultsThe probability of LNM, central lymph node metastasis (CLNM) and lateral lymph node metastasis(LLNM)of PTMC patients were 35.6, 33.7 and 5.6%, respectively. In addition, 1.9% PTMC had LLNM only. Male, age ≤ 40 years, tumor largest diameter ≥ 5 mm, multifocal, non-uniform echoic distribution, the sum of the maximum diameter of multifocal in a unilateral lobe ≥ 8.5 mm, tumors in the lower pole location were prone to CLNM. Ultrasound mix-echo, the sum of the maximum diameter of the multifocal ≥ 10.75 mm, tumors in the upper pole location were extremely prone to LLNM. T3 were prone to LLNM or skip LLNM.

conclusionsAccording to the clinicopathological characteristics of PTMC, the cervical lymph nodes should be correctly evaluated to guide the surgical treatment.

Indexed as

AdolescentAdultAgedAge FactorsFemaleHumansLymphatic MetastasisLymph NodesMaleMiddle AgedRetrospective StudiesRisk AssessmentRisk FactorsSex FactorsThyroid Cancer, PapillaryThyroid NeoplasmsLymph node metastasisNeck dissectionPapillary thyroid microcarcinomaRisk factors

Identifiers

PMID29876836
PMCPMC6394766
OpenAlexW2807587761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.